Unique ID issued by UMIN | UMIN000008365 |
---|---|
Receipt number | R000009806 |
Scientific Title | A Prospective, Single-center Investigation of the Performance of the V-Loc 180 in a Gastrectomy for Gastric Cancer |
Date of disclosure of the study information | 2012/07/06 |
Last modified on | 2014/03/03 10:23:17 |
A Prospective, Single-center Investigation of the Performance of the V-Loc 180 in a Gastrectomy for Gastric Cancer
A Prospective, Single-center Investigation of the Performance of the V-Loc 180 in a Gastrectomy for Gastric Cancer
A Prospective, Single-center Investigation of the Performance of the V-Loc 180 in a Gastrectomy for Gastric Cancer
A Prospective, Single-center Investigation of the Performance of the V-Loc 180 in a Gastrectomy for Gastric Cancer
Japan |
Gastric cancer
Gastrointestinal surgery |
Malignancy
NO
To investigate the performance of the barbed suture V-Loc180 for closure of the access opening to create an intracorporeal anastomosis using a stapler after laparoscopic gastrectomy.
Efficacy
Incidence of postoperative leak at the site where V-Loc180 was applied
Interventional
Single arm
Non-randomized
Single blind -participants are blinded
Uncontrolled
1
Treatment
Device,equipment |
V-Loc 180
20 | years-old | <= |
Not applicable |
Male and Female
1) Reconstruction is scheduled by functional end-to-end anastomosis or side-to-side anastomosis using a stapler in laparoscopic gastrectomy.
2) Age: 20 years or older.
3) No past history of surgery to the upper abdomen except laparoscopic cholecystectomy.
4) Eastern Cooperative Oncology Group Scale of Performance Status (ECOG PS) of either 0 or 1.
5) The functions of the major organs are maintained.
6) Informed consent to participate in the study is obtained from the patient him/herself in writing.
1) Women who are pregnant/possibly pregnant or breastfeeding.
2) Patients who are continuing to use a systemic steroid preparation (oral or intravenous).
3) Patients with the complication of poorly controlled diabetes mellitus (HbA1C>8.0).
4) Patients who are allergic to nickel chrome (as specified in the package insert).
5) Patients with the complication of psychiatric disorders or psychiatric symptoms, and who are judged to have difficulty participating in the study.
6) Other patients who are considered not suitable for participation in this study by the physician in charge.
50
1st name | |
Middle name | |
Last name | Kazuhisa Uchiyama |
Osaka Medical College
Department of General and Gastrointestinal Surgery
2-7 Daigaku-machi, Takatsuki City, Osaka, 569-8686
1st name | |
Middle name | |
Last name | Sang-woong Lee |
Osaka Medical College
Department of General and Gastrointestinal Surgery
072-683-1221
Department of General and Gastrointestinal Surgery, Osaka Medical College
Covidien Japan Inc.
Profit organization
NO
2012 | Year | 07 | Month | 06 | Day |
Unpublished
Completed
2012 | Year | 03 | Month | 19 | Day |
2012 | Year | 07 | Month | 01 | Day |
2012 | Year | 07 | Month | 06 | Day |
2014 | Year | 03 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009806